# Eliquis Acute Stroke Safety Evaluation

> **NCT04435418** · — · COMPLETED · sponsor: **University of Alberta** · enrollment: 100 (actual)

## Conditions studied

- Ischemic Stroke
- Transient Ischemic Attack
- Atrial Fibrillation

## Interventions

- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT04435418
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2019-09-09
- **Final completion:** 2019-09-09
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04435418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04435418, "Eliquis Acute Stroke Safety Evaluation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04435418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*